Antigen Pool Decoding for Accurate Lymphocyte Receptor Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for determining lymphocyte receptor sequences that recognize specific antigens suffer from high false positive and false negative rates, and there is a need for improved assays to accurately identify lymphocyte receptor chain sequences that bind to specific antigens in pool-based detection formats.

Innovation Solution

A method involving sorting antigens into unique subsets, contacting biological samples with lymphocytes, separating target lymphocytes, sequencing their nucleic acids, and using decoding algorithms to detect specific lymphocyte receptor chain sequences, with error-correcting codes to enhance accuracy and sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If pool-based detection formats are used to determine lymphocyte receptor sequences, then productivity is improved by testing multiple antigens simultaneously, but measurement precision deteriorates due to high false positive and false negative rates

Engineering Contradiction:
Improvethroughput of antigen testingVSAvoidaccuracy of lymphocyte receptor sequence identification
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent divides the pool-based detection into multiple sub-pools or reaction mixtures, where each antigen is assigned to specific subsets. By segmenting the detection process and using decoding algorithms to interpret patterns across subsets, the method maintains high throughput while improving accuracy in identifying specific lymphocyte-antigen interactions

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs decoding algorithms that analyze detection patterns across multiple reaction mixtures to provide feedback on the reliability of identified lymphocyte-antigen interactions. This computational feedback mechanism helps distinguish true positives from false positives and negatives, thereby improving measurement precision while maintaining pool-based productivity

Inventive Principle:
Principle #23Feedback

2Measurement precision

If conventional single-antigen testing methods are used, then measurement precision is maintained with accurate identification, but productivity deteriorates due to sequential testing requirements

Engineering Contradiction:
Improveaccuracy of lymphocyte receptor sequence identificationVSAvoidthroughput of antigen testing
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent merges multiple single-antigen tests into a single pool-based detection format where multiple antigens are tested simultaneously. By combining detection reactions and using computational decoding to resolve individual antigen-specific responses, the method achieves both high productivity and maintained measurement precision

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If error-correcting codes are implemented in the detection algorithm, then reliability is improved by reducing false positives and negatives, but device complexity increases due to computational requirements

Engineering Contradiction:
Improveaccuracy of antigen specificity determinationVSAvoidcomplexity of decoding algorithm system
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent introduces computational decoding algorithms as an intermediary between the pool-based detection data and the final identification of lymphocyte-antigen interactions. This computational mediator processes the complex pattern data from multiple reaction mixtures, applying error-correcting logic to reliably identify specific interactions while managing system complexity through software rather than hardware complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12486501B2Multiplexed testing of lymphocytes for antigen specificity
Publication Date: 2025.12.02 THINK THERAPEUTICS INC
  • US12486501B2 patent drawing
  • US12486501B2 patent drawing

AI summary

Described herein is a method for determining a lymphocyte cell receptor chain sequence specific to a unique antigen, comprising: sorting a plurality of antigens into a plurality of reaction mixtures, wherein the sorting comprises adding a unique antigen of the plurality of antigens to a unique subset of the plurality of reaction mixtures such that two different unique antigens are not added to the unique subset; contacting each reaction with a biological sample comprising a plurality of lymphocytes; separating a target lymphocyte from a subset of the plurality of lymphocytes, wherein the target lymphocyte recognizes the unique antigen; after separating the target lymphocyte, sequencing nucleic acids of the target lymphocyte to obtain the lymphocyte receptor chain sequence, wherein the sequencing is performed by single-cell sequencing; and detecting the unique antigen, wherein the detecting comprises: computing a frequency of lymphocyte cells that express the lymphocyte receptor chain sequence.